Pegylated liposomal doxorubicin plus adebrelimab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

Obstetrics & Gynecology Hospital of Fudan University1

Indications

Ovarian Cancer Recurrent1
Cancer1

Other1 trial

Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.